Article
Equitable Tolling May Be Product Of Patent Office's New Math On Patent Term Extensions
Idera Pharmaceuticals is challenging recently enacted interim procedures for revising patent term extensions as being inequitable.

Bracewell LLP
Use advanced search filters to refine your search

